Publication:
Clinical evaluation of three KRS families and cellular analysis of distinct ATP13A2 mutations reveal different levels of Iron accumulation

dc.contributor.coauthorErterek, E.
dc.contributor.coauthorTemizci, B.
dc.contributor.coauthorÇakır, B.
dc.contributor.coauthorGültekin, M.
dc.contributor.coauthorYapıcı, Z.
dc.contributor.coauthorKarabay, A.
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBaşak, Ayşe Nazlı
dc.contributor.kuauthorTekgül, Şeyma
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-07-07T08:48:43Z
dc.date.issued2026
dc.description.abstractKufor‐Rakeb Syndrome (KRS) is a rare neurodegenerative disease caused by homozygous mutations in the ATP13A2 gene. The ATP13A2 protein, found in lysosomal and late‐endosomal membranes, performs cellular functions such as iron‐chelating agent transport and intracellular iron homeostasis. Mutations in ATP13A2 can lead to intracellular iron accumulation; however, whether KRS caused by an ATP13A2 mutation falls under Neurodegeneration with Brain Iron Accumulation disorders has long been debated. The most fundamental reason is that magnetic resonance imaging (MRI) cannot identify iron deposits in the basal ganglia in all KRS cases. We hypothesize that analyzing iron deposition at the cellular level could be more sensitive in detecting varying levels of iron accumulation associated with different ATP13A2 mutations, and it may be more useful when conventional MRI fails to detect iron, yields inconclusive results, or cannot be performed. We identified two new ATP13A2 mutations (p.Leu518_Thr519del, and p.Leu939Pro) in this study and comparatively investigated the impacts of three distinct ATP13A2 mutations (p.Pro474fs, p.Leu518_Thr519del, and p.Leu939Pro) using KRS patients' primary fibroblasts and MCF7 cells overexpressing these mutated ATP13A2 proteins to analyze if these different mutations of ATP13A2 can cause differing levels of iron accumulation. Following the detection of iron deposits via Prussian blue staining and inductively coupled plasma mass spectrometry, the cell viability was assessed via MTT assay to ascertain the impact of iron accumulation. Each type of ATP13A2 mutation led to iron accumulation; however, frameshift and deletion mutations resulted in more iron accumulation than the missense mutation. In addition, the transient overexpression of the wild‐type ATP13A2 attenuated the cell death caused by iron accumulation. This study demonstrated that different types of ATP13A2 mutations are related to varying levels of iron accumulation and provided an explanation for the inconsistent perspectives on the association of KRS with iron accumulation. image
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThis work was supported by Health Institute of Turkiye (TUSEB) Project # 28599 to Arzu Karabay (AK) and Istanbul Technical University BAP Project # TYL-2021-43140 to AK and EE.
dc.description.versionPublished Version
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1111/jnc.70418
dc.identifier.eissn1471-4159
dc.identifier.embargoN/A
dc.identifier.grantno28599
dc.identifier.grantnoTYL‐2021‐43140
dc.identifier.issn0022-3042
dc.identifier.issue4
dc.identifier.pubmed41944191
dc.identifier.scopus2-s2.0-105035037111
dc.identifier.urihttp://doi.org/10.1111/jnc.70418
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33228
dc.identifier.volume170
dc.identifier.wos001752505300015
dc.keywordsATP13A2
dc.keywordsIron
dc.keywordsKufor-Rakeb syndrome
dc.keywordsNBIA
dc.keywordsNovel mutation
dc.keywordsParkinson's disease
dc.languageeng
dc.publisherWiley
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJournal of Neurochemistry
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectBiochemistry
dc.subjectMolecular biology
dc.subjectNeurosciences
dc.titleClinical evaluation of three KRS families and cellular analysis of distinct ATP13A2 mutations reveal different levels of Iron accumulation
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscoveryd437580f-9309-4ecb-864a-4af58309d287

Files